Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;51(6):820-8.
doi: 10.1007/s00120-011-2769-2.

[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]

[Article in German]
Affiliations
Review

[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]

[Article in German]
M Rink et al. Urologe A. 2012 Jun.

Abstract

Introduction: Age is suggested to be the greatest single risk factor for developing urothelial carcinoma of the bladder (UCB). This review presents an overview of the incidence, prognosis, surgical and medical therapy of UCB in elderly patients (> 65 years).

Results: Elderly patients have an approximate 11-fold increase in the incidence and a 15-fold increase in UCB mortality when compared to younger individuals. However, adequate surgical or medical treatment is less often or delayed offered to elderly patients. In properly selected cases, similar surgical outcomes and complication rates are reported in elderly patients, regardless of the type of urinary diversion. Application of perioperative systemic chemotherapy is dependent on physiologic deterioration and comorbidities. An adequate, restrictive case selection and early proactive postoperative rehabilitation are important factors to achieve good results.

Conclusions: In adequately selected elderly patients, radical cystectomy and urinary diversion as well as systemic chemotherapy are feasible, safe and efficacious treatment options for advanced UCB.

PubMed Disclaimer

Similar articles

Cited by

References

    1. BJU Int. 2005 Jun;95(9):1211-4 - PubMed
    1. Oncology. 2007;73(5-6):290-7 - PubMed
    1. Cancer. 2006 Aug 1;107(3):506-13 - PubMed
    1. J Urol. 2004 Oct;172(4 Pt 1):1323-7 - PubMed
    1. Eur Urol. 2005 Aug;48(2):189-199; discussion 199-201 - PubMed

Substances

LinkOut - more resources